SS Innovations International (SSII) Change in Receivables (2022 - 2026)
SS Innovations International (SSII) reported Change in Receivables of $245111.0 for Q1 2026, up 119.21% on a YoY basis from $111814.0 in Q1 2025, and down 96.47% sequentially from $7.0 million in Q4 2025.
SS Innovations International (SSII) Change in Receivables (2022 - 2026) Analysis & Trends
SS Innovations International (SSII) has 5 years of Change in Receivables data on file, last reported at $245111.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 119.21% year-over-year to $245111.0; the trailing twelve-month figure through Mar 2026 stood at $14.6 million (up 3300.05% YoY), and the FY2025 full-year result was $13.0 million, up 166.61% from the prior year.
- Change in Receivables retreated to $245111.0 in Q1 2026, from $7.0 million in the prior quarter.
- In the past five years, Change in Receivables ranged from a high of $7.0 million in Q4 2025 to a low of -$1.3 million in Q1 2025.
- A 5-year average of $1.5 million and a median of $545282.0 in 2022 frame the typical range for Change in Receivables.
- Across the five-year window, Change in Receivables jumped 1572.68% in 2024 and tumbled 140.04% in 2025, its largest moves.
- Tracing SSII's Change in Receivables over 5 years: stood at $399630.0 in 2022, then rose by 11.15% to $444183.0 in 2023, then jumped by 158.64% to $1.1 million in 2024, then surged by 504.99% to $7.0 million in 2025, then tumbled by 96.47% to $245111.0 in 2026.
- Business Quant data shows SSII's Change in Receivables at $245111.0 in Q1 2026, $7.0 million in Q4 2025, and $3.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 287.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -124.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SS Innovations International | 699.75 Mn | 676.14 Mn | 5.33 Mn | 245,111.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 245,111.00 |
| Mar 31, 2026 | 245,111.00 |
| Dec 31, 2025 | 6.95 Mn |
| Dec 31, 2025 | 6.95 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Sep 30, 2025 | 3.75 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Jun 30, 2025 | 3.61 Mn |
| Mar 31, 2025 | -1.28 Mn |
| Mar 31, 2025 | -1.28 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Dec 31, 2024 | 1.15 Mn |
| Sep 30, 2024 | 265,313.00 |
| Sep 30, 2024 | 265,313.00 |
| Jun 30, 2024 | 289,770.00 |
| Jun 30, 2024 | 289,770.00 |
| Mar 31, 2024 | 3.19 Mn |
| Mar 31, 2024 | 3.19 Mn |
| Dec 31, 2023 | 444,183.00 |
| Dec 31, 2023 | 444,183.00 |